Issues related to, 
Tax Reform, Generally;
Tax Cuts and Jobs Act of 2017 (P.L. 115-97) H.R. 3, Lower Drug Costs Now Act of 2019, including provisions relating to international reference pricing
H.R. 19, Lower Costs, More Cures Act of 2019
H.R. 133, Consolidated Appropriations Act of 2021, including provision relating to vaccine funding and vaccinations
H.R. 4100/S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019. including provisions relating to Anti-microbial Resistance
H.R. 4455, Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act
H.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019
H.R. 4629, Star Rating for Biosimilars Act
H.R. 6197, Increasing Access to Biosimilars Act of 2020
H.R. 8061, Community Immunity During COVID-19 Act of 2020
H.R. 8920, The Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2020
S. 1895, Lower Health Care Costs Act
S. 2543, Prescription Drug Pricing Reduction Act of 2019
S. 4760, The Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act 2020

Issues relating to,
340B Reforms; 
340B program integrity;
340B of the Public Health Services Act;
340B policy;
340 drug pricing program;
Drug pricing; 
Anti-microbial Resistance; 
Biosimilars;
Maternal Health;
Cost and value of medicines;
Vaccines;
Supply chain;
COVID-19 vaccines;
COVID-19 issues;
Vaccines catch up;
General pharmaceutical issues;
Average Manufacture Price (AMP) cap;
Executive Order 13937, Access to Affordable Life-Saving Medications;
Department of Agriculture Center for Veterinary Biologics (CVB) funding. H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs
S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019
S. 2543, Prescription Drug Pricing Reduction Act of 2019, including provisions relating to AMP cap and Medicare Part D rebate

Issues relating to, 
Medicaid; 
Medicare; 
Medicare Part B;  
Medicare Part B and D drug pricing issues;
340B reforms;
340B program integrity;
340B of the Public Health Services Act;
340B drug pricing issues;
Medicare Part D; 
Drug Pricing;
Center for Medicare and Medicaid demonstrations.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MERCK & CO, INC.
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07003, US
BRADLEY ALLEN ROSSIN ADAM HUFTALEN BRADLEY ALLEN ROSSIN ELIZABETH SCHWARTZ ERIN DARLING COREY MALMGREN ROBERT FILIPPONE ADAM HUFTALEN BRADLEY ALLEN ROSSIN ROBERT FILIPPONE ELIZABETH SCHWARTZ COREY MALMGREN ERIN DARLING ADAM HUFTALEN